nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Rivastigmine—Alzheimer's disease	0.144	0.432	CbGbCtD
Imiquimod—CYP3A4—Donepezil—Alzheimer's disease	0.115	0.345	CbGbCtD
Imiquimod—CYP3A4—Galantamine—Alzheimer's disease	0.074	0.223	CbGbCtD
Imiquimod—TLR7—Immune System—PLD3—Alzheimer's disease	0.000633	0.00356	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—Alzheimer's disease	0.000619	0.00348	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000618	0.00348	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000613	0.00345	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK8—Alzheimer's disease	0.000611	0.00344	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00061	0.00343	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000609	0.00342	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CTSB—Alzheimer's disease	0.000608	0.00342	CbGpPWpGaD
Imiquimod—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000607	0.00124	CcSEcCtD
Imiquimod—Myocardial infarction—Memantine—Alzheimer's disease	0.000607	0.00124	CcSEcCtD
Imiquimod—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000606	0.00124	CcSEcCtD
Imiquimod—Infestation—Rivastigmine—Alzheimer's disease	0.000606	0.00124	CcSEcCtD
Imiquimod—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000604	0.00123	CcSEcCtD
Imiquimod—Loss of consciousness—Galantamine—Alzheimer's disease	0.000604	0.00123	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK8—Alzheimer's disease	0.000604	0.0034	CbGpPWpGaD
Imiquimod—Depression—Rivastigmine—Alzheimer's disease	0.000604	0.00123	CcSEcCtD
Imiquimod—Urinary tract infection—Memantine—Alzheimer's disease	0.000602	0.00123	CcSEcCtD
Imiquimod—Conjunctivitis—Memantine—Alzheimer's disease	0.000602	0.00123	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.0006	0.00123	CcSEcCtD
Imiquimod—Urethral disorder—Donepezil—Alzheimer's disease	0.0006	0.00122	CcSEcCtD
Imiquimod—Cough—Galantamine—Alzheimer's disease	0.0006	0.00122	CcSEcCtD
Imiquimod—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000597	0.00122	CcSEcCtD
Imiquimod—Convulsion—Galantamine—Alzheimer's disease	0.000596	0.00122	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PPP3CA—Alzheimer's disease	0.000595	0.00335	CbGpPWpGaD
Imiquimod—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000594	0.00121	CcSEcCtD
Imiquimod—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000594	0.00121	CcSEcCtD
Imiquimod—Hypertension—Galantamine—Alzheimer's disease	0.000593	0.00121	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK8—Alzheimer's disease	0.000593	0.00334	CbGpPWpGaD
Imiquimod—Visual impairment—Donepezil—Alzheimer's disease	0.00059	0.0012	CcSEcCtD
Imiquimod—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000589	0.0012	CcSEcCtD
Imiquimod—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000589	0.0012	CcSEcCtD
Imiquimod—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000585	0.00119	CcSEcCtD
Imiquimod—Arthralgia—Galantamine—Alzheimer's disease	0.000585	0.00119	CcSEcCtD
Imiquimod—Chest pain—Galantamine—Alzheimer's disease	0.000585	0.00119	CcSEcCtD
Imiquimod—Myalgia—Galantamine—Alzheimer's disease	0.000585	0.00119	CcSEcCtD
Imiquimod—TLR8—Immune System—PIN1—Alzheimer's disease	0.000584	0.00329	CbGpPWpGaD
Imiquimod—Anxiety—Galantamine—Alzheimer's disease	0.000583	0.00119	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000581	0.00119	CcSEcCtD
Imiquimod—Sinusitis—Memantine—Alzheimer's disease	0.000581	0.00119	CcSEcCtD
Imiquimod—Discomfort—Galantamine—Alzheimer's disease	0.000578	0.00118	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Alzheimer's disease	0.000573	0.00322	CbGpPWpGaD
Imiquimod—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000573	0.00117	CcSEcCtD
Imiquimod—Dry mouth—Galantamine—Alzheimer's disease	0.000572	0.00117	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—GAB2—Alzheimer's disease	0.000571	0.00321	CbGpPWpGaD
Imiquimod—Tinnitus—Donepezil—Alzheimer's disease	0.000571	0.00116	CcSEcCtD
Imiquimod—Sinusitis—Rivastigmine—Alzheimer's disease	0.000568	0.00116	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—GSK3A—Alzheimer's disease	0.000566	0.00318	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CR1—Alzheimer's disease	0.000564	0.00317	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—Alzheimer's disease	0.000562	0.00316	CbGpPWpGaD
Imiquimod—Haemoglobin—Memantine—Alzheimer's disease	0.000558	0.00114	CcSEcCtD
Imiquimod—Rhinitis—Memantine—Alzheimer's disease	0.000557	0.00114	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—APP—Alzheimer's disease	0.000556	0.00313	CbGpPWpGaD
Imiquimod—Haemorrhage—Memantine—Alzheimer's disease	0.000556	0.00113	CcSEcCtD
Imiquimod—TLR8—Immune System—CFH—Alzheimer's disease	0.000555	0.00312	CbGpPWpGaD
Imiquimod—Shock—Galantamine—Alzheimer's disease	0.000552	0.00113	CcSEcCtD
Imiquimod—Pharyngitis—Memantine—Alzheimer's disease	0.000551	0.00113	CcSEcCtD
Imiquimod—Nervous system disorder—Galantamine—Alzheimer's disease	0.00055	0.00112	CcSEcCtD
Imiquimod—Chills—Donepezil—Alzheimer's disease	0.000549	0.00112	CcSEcCtD
Imiquimod—Urinary tract disorder—Memantine—Alzheimer's disease	0.000549	0.00112	CcSEcCtD
Imiquimod—Tachycardia—Galantamine—Alzheimer's disease	0.000548	0.00112	CcSEcCtD
Imiquimod—Arrhythmia—Donepezil—Alzheimer's disease	0.000547	0.00112	CcSEcCtD
Imiquimod—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000546	0.00112	CcSEcCtD
Imiquimod—Connective tissue disorder—Memantine—Alzheimer's disease	0.000546	0.00111	CcSEcCtD
Imiquimod—Rhinitis—Rivastigmine—Alzheimer's disease	0.000545	0.00111	CcSEcCtD
Imiquimod—Skin disorder—Galantamine—Alzheimer's disease	0.000545	0.00111	CcSEcCtD
Imiquimod—Urethral disorder—Memantine—Alzheimer's disease	0.000545	0.00111	CcSEcCtD
Imiquimod—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000544	0.00111	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—Alzheimer's disease	0.000543	0.00305	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000542	0.00111	CcSEcCtD
Imiquimod—Alopecia—Donepezil—Alzheimer's disease	0.000541	0.0011	CcSEcCtD
Imiquimod—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00054	0.0011	CcSEcCtD
Imiquimod—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000537	0.0011	CcSEcCtD
Imiquimod—Mental disorder—Donepezil—Alzheimer's disease	0.000536	0.00109	CcSEcCtD
Imiquimod—Visual impairment—Memantine—Alzheimer's disease	0.000535	0.00109	CcSEcCtD
Imiquimod—Anorexia—Galantamine—Alzheimer's disease	0.000535	0.00109	CcSEcCtD
Imiquimod—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000534	0.00109	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000533	0.003	CbGpPWpGaD
Imiquimod—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Imiquimod—Erythema—Donepezil—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Imiquimod—Malnutrition—Donepezil—Alzheimer's disease	0.000533	0.00109	CcSEcCtD
Imiquimod—Erythema multiforme—Memantine—Alzheimer's disease	0.000525	0.00107	CcSEcCtD
Imiquimod—Visual impairment—Rivastigmine—Alzheimer's disease	0.000524	0.00107	CcSEcCtD
Imiquimod—Eye disorder—Memantine—Alzheimer's disease	0.000519	0.00106	CcSEcCtD
Imiquimod—Tinnitus—Memantine—Alzheimer's disease	0.000518	0.00106	CcSEcCtD
Imiquimod—Flushing—Memantine—Alzheimer's disease	0.000516	0.00105	CcSEcCtD
Imiquimod—Back pain—Donepezil—Alzheimer's disease	0.000515	0.00105	CcSEcCtD
Imiquimod—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000514	0.00105	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000511	0.00104	CcSEcCtD
Imiquimod—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000509	0.00286	CbGpPWpGaD
Imiquimod—Eye disorder—Rivastigmine—Alzheimer's disease	0.000508	0.00104	CcSEcCtD
Imiquimod—Insomnia—Galantamine—Alzheimer's disease	0.000507	0.00104	CcSEcCtD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—ESR1—Alzheimer's disease	0.000507	0.00285	CbGpPWpGaD
Imiquimod—Tinnitus—Rivastigmine—Alzheimer's disease	0.000507	0.00103	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—Alzheimer's disease	0.000505	0.00284	CbGpPWpGaD
Imiquimod—Flushing—Rivastigmine—Alzheimer's disease	0.000504	0.00103	CcSEcCtD
Imiquimod—Angiopathy—Memantine—Alzheimer's disease	0.000504	0.00103	CcSEcCtD
Imiquimod—Paraesthesia—Galantamine—Alzheimer's disease	0.000504	0.00103	CcSEcCtD
Imiquimod—Immune system disorder—Memantine—Alzheimer's disease	0.000502	0.00102	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000501	0.00282	CbGpPWpGaD
Imiquimod—Mediastinal disorder—Memantine—Alzheimer's disease	0.000501	0.00102	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—Alzheimer's disease	0.0005	0.00281	CbGpPWpGaD
Imiquimod—Somnolence—Galantamine—Alzheimer's disease	0.000499	0.00102	CcSEcCtD
Imiquimod—Chills—Memantine—Alzheimer's disease	0.000499	0.00102	CcSEcCtD
Imiquimod—TLR8—Immune System—PVRL2—Alzheimer's disease	0.000497	0.00279	CbGpPWpGaD
Imiquimod—Arrhythmia—Memantine—Alzheimer's disease	0.000496	0.00101	CcSEcCtD
Imiquimod—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000494	0.00101	CcSEcCtD
Imiquimod—Dyspepsia—Galantamine—Alzheimer's disease	0.000494	0.00101	CcSEcCtD
Imiquimod—Angiopathy—Rivastigmine—Alzheimer's disease	0.000493	0.00101	CcSEcCtD
Imiquimod—Alopecia—Memantine—Alzheimer's disease	0.000491	0.001	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	0.00049	0.00276	CbGpPWpGaD
Imiquimod—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00049	0.001	CcSEcCtD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00049	0.00275	CbGpPWpGaD
Imiquimod—Agitation—Donepezil—Alzheimer's disease	0.00049	0.000999	CcSEcCtD
Imiquimod—Chills—Rivastigmine—Alzheimer's disease	0.000488	0.000996	CcSEcCtD
Imiquimod—Decreased appetite—Galantamine—Alzheimer's disease	0.000488	0.000995	CcSEcCtD
Imiquimod—Mental disorder—Memantine—Alzheimer's disease	0.000487	0.000994	CcSEcCtD
Imiquimod—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000486	0.000991	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000484	0.000989	CcSEcCtD
Imiquimod—Malnutrition—Memantine—Alzheimer's disease	0.000484	0.000987	CcSEcCtD
Imiquimod—Fatigue—Galantamine—Alzheimer's disease	0.000484	0.000987	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—Alzheimer's disease	0.000483	0.00272	CbGpPWpGaD
Imiquimod—Malaise—Donepezil—Alzheimer's disease	0.00048	0.000981	CcSEcCtD
Imiquimod—Alopecia—Rivastigmine—Alzheimer's disease	0.00048	0.00098	CcSEcCtD
Imiquimod—Syncope—Donepezil—Alzheimer's disease	0.000478	0.000975	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000477	0.00268	CbGpPWpGaD
Imiquimod—Mental disorder—Rivastigmine—Alzheimer's disease	0.000476	0.000972	CcSEcCtD
Imiquimod—Erythema—Rivastigmine—Alzheimer's disease	0.000473	0.000966	CcSEcCtD
Imiquimod—Malnutrition—Rivastigmine—Alzheimer's disease	0.000473	0.000966	CcSEcCtD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000471	0.00265	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—Alzheimer's disease	0.000469	0.00264	CbGpPWpGaD
Imiquimod—Loss of consciousness—Donepezil—Alzheimer's disease	0.000468	0.000956	CcSEcCtD
Imiquimod—Back pain—Memantine—Alzheimer's disease	0.000468	0.000955	CcSEcCtD
Imiquimod—Cough—Donepezil—Alzheimer's disease	0.000465	0.000949	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK8—Alzheimer's disease	0.000463	0.0026	CbGpPWpGaD
Imiquimod—Feeling abnormal—Galantamine—Alzheimer's disease	0.000462	0.000944	CcSEcCtD
Imiquimod—Convulsion—Donepezil—Alzheimer's disease	0.000462	0.000942	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—Alzheimer's disease	0.000461	0.00259	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CTSB—Alzheimer's disease	0.000461	0.00259	CbGpPWpGaD
Imiquimod—Hypertension—Donepezil—Alzheimer's disease	0.00046	0.000939	CcSEcCtD
Imiquimod—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000459	0.000936	CcSEcCtD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK8—Alzheimer's disease	0.000458	0.00258	CbGpPWpGaD
Imiquimod—Back pain—Rivastigmine—Alzheimer's disease	0.000458	0.000934	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000456	0.00256	CbGpPWpGaD
Imiquimod—Chest pain—Donepezil—Alzheimer's disease	0.000454	0.000926	CcSEcCtD
Imiquimod—Arthralgia—Donepezil—Alzheimer's disease	0.000454	0.000926	CcSEcCtD
Imiquimod—Myalgia—Donepezil—Alzheimer's disease	0.000454	0.000926	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—S100B—Alzheimer's disease	0.000452	0.00254	CbGpPWpGaD
Imiquimod—Anxiety—Donepezil—Alzheimer's disease	0.000452	0.000923	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PPP3CA—Alzheimer's disease	0.000451	0.00254	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EIF2AK2—Alzheimer's disease	0.000451	0.00254	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Memantine—Alzheimer's disease	0.000449	0.000916	CcSEcCtD
Imiquimod—Discomfort—Donepezil—Alzheimer's disease	0.000448	0.000915	CcSEcCtD
Imiquimod—Agitation—Memantine—Alzheimer's disease	0.000445	0.000907	CcSEcCtD
Imiquimod—Dry mouth—Donepezil—Alzheimer's disease	0.000444	0.000905	CcSEcCtD
Imiquimod—Body temperature increased—Galantamine—Alzheimer's disease	0.000443	0.000905	CcSEcCtD
Imiquimod—Abdominal pain—Galantamine—Alzheimer's disease	0.000443	0.000905	CcSEcCtD
Imiquimod—TLR7—Immune System—PIN1—Alzheimer's disease	0.000443	0.00249	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000439	0.000896	CcSEcCtD
Imiquimod—Malaise—Memantine—Alzheimer's disease	0.000436	0.00089	CcSEcCtD
Imiquimod—Agitation—Rivastigmine—Alzheimer's disease	0.000435	0.000888	CcSEcCtD
Imiquimod—Oedema—Donepezil—Alzheimer's disease	0.000435	0.000887	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Alzheimer's disease	0.000434	0.00244	CbGpPWpGaD
Imiquimod—Syncope—Memantine—Alzheimer's disease	0.000434	0.000885	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—GAB2—Alzheimer's disease	0.000433	0.00243	CbGpPWpGaD
Imiquimod—Infection—Donepezil—Alzheimer's disease	0.000432	0.000882	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—GSK3A—Alzheimer's disease	0.000429	0.00241	CbGpPWpGaD
Imiquimod—Shock—Donepezil—Alzheimer's disease	0.000428	0.000873	CcSEcCtD
Imiquimod—TLR7—Immune System—CR1—Alzheimer's disease	0.000428	0.00241	CbGpPWpGaD
Imiquimod—Palpitations—Memantine—Alzheimer's disease	0.000427	0.000872	CcSEcCtD
Imiquimod—Malaise—Rivastigmine—Alzheimer's disease	0.000427	0.000871	CcSEcCtD
Imiquimod—Nervous system disorder—Donepezil—Alzheimer's disease	0.000426	0.00087	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—Alzheimer's disease	0.000426	0.0024	CbGpPWpGaD
Imiquimod—Loss of consciousness—Memantine—Alzheimer's disease	0.000425	0.000868	CcSEcCtD
Imiquimod—Syncope—Rivastigmine—Alzheimer's disease	0.000424	0.000866	CcSEcCtD
Imiquimod—Cough—Memantine—Alzheimer's disease	0.000422	0.000862	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—APP—Alzheimer's disease	0.000422	0.00237	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CFH—Alzheimer's disease	0.000421	0.00237	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00042	0.000858	CcSEcCtD
Imiquimod—Convulsion—Memantine—Alzheimer's disease	0.000419	0.000855	CcSEcCtD
Imiquimod—Palpitations—Rivastigmine—Alzheimer's disease	0.000418	0.000854	CcSEcCtD
Imiquimod—Hypertension—Memantine—Alzheimer's disease	0.000418	0.000852	CcSEcCtD
Imiquimod—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000416	0.000849	CcSEcCtD
Imiquimod—Anorexia—Donepezil—Alzheimer's disease	0.000414	0.000846	CcSEcCtD
Imiquimod—Hypersensitivity—Galantamine—Alzheimer's disease	0.000413	0.000844	CcSEcCtD
Imiquimod—Cough—Rivastigmine—Alzheimer's disease	0.000413	0.000843	CcSEcCtD
Imiquimod—Chest pain—Memantine—Alzheimer's disease	0.000412	0.000841	CcSEcCtD
Imiquimod—Myalgia—Memantine—Alzheimer's disease	0.000412	0.000841	CcSEcCtD
Imiquimod—Arthralgia—Memantine—Alzheimer's disease	0.000412	0.000841	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—Alzheimer's disease	0.000411	0.00231	CbGpPWpGaD
Imiquimod—Anxiety—Memantine—Alzheimer's disease	0.00041	0.000838	CcSEcCtD
Imiquimod—Convulsion—Rivastigmine—Alzheimer's disease	0.00041	0.000837	CcSEcCtD
Imiquimod—Hypertension—Rivastigmine—Alzheimer's disease	0.000409	0.000834	CcSEcCtD
Imiquimod—Discomfort—Memantine—Alzheimer's disease	0.000407	0.00083	CcSEcCtD
Imiquimod—Arthralgia—Rivastigmine—Alzheimer's disease	0.000403	0.000822	CcSEcCtD
Imiquimod—Chest pain—Rivastigmine—Alzheimer's disease	0.000403	0.000822	CcSEcCtD
Imiquimod—Myalgia—Rivastigmine—Alzheimer's disease	0.000403	0.000822	CcSEcCtD
Imiquimod—Dry mouth—Memantine—Alzheimer's disease	0.000403	0.000822	CcSEcCtD
Imiquimod—Asthenia—Galantamine—Alzheimer's disease	0.000403	0.000822	CcSEcCtD
Imiquimod—Anxiety—Rivastigmine—Alzheimer's disease	0.000401	0.000819	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0004	0.000817	CcSEcCtD
Imiquimod—Discomfort—Rivastigmine—Alzheimer's disease	0.000398	0.000812	CcSEcCtD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000396	0.00223	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000396	0.000809	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MEF2C—Alzheimer's disease	0.000396	0.00223	CbGpPWpGaD
Imiquimod—Oedema—Memantine—Alzheimer's disease	0.000395	0.000806	CcSEcCtD
Imiquimod—Dry mouth—Rivastigmine—Alzheimer's disease	0.000394	0.000804	CcSEcCtD
Imiquimod—Insomnia—Donepezil—Alzheimer's disease	0.000393	0.000803	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—AGER—Alzheimer's disease	0.000392	0.00221	CbGpPWpGaD
Imiquimod—Infection—Memantine—Alzheimer's disease	0.000392	0.0008	CcSEcCtD
Imiquimod—Paraesthesia—Donepezil—Alzheimer's disease	0.00039	0.000797	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—Alzheimer's disease	0.00039	0.00219	CbGpPWpGaD
Imiquimod—Shock—Memantine—Alzheimer's disease	0.000388	0.000793	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PRKCG—Alzheimer's disease	0.000388	0.00218	CbGpPWpGaD
Imiquimod—Dyspnoea—Donepezil—Alzheimer's disease	0.000388	0.000791	CcSEcCtD
Imiquimod—Nervous system disorder—Memantine—Alzheimer's disease	0.000387	0.00079	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000387	0.00217	CbGpPWpGaD
Imiquimod—Somnolence—Donepezil—Alzheimer's disease	0.000387	0.000789	CcSEcCtD
Imiquimod—Oedema—Rivastigmine—Alzheimer's disease	0.000386	0.000788	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—Alzheimer's disease	0.000386	0.00217	CbGpPWpGaD
Imiquimod—Tachycardia—Memantine—Alzheimer's disease	0.000385	0.000786	CcSEcCtD
Imiquimod—Diarrhoea—Galantamine—Alzheimer's disease	0.000384	0.000783	CcSEcCtD
Imiquimod—Infection—Rivastigmine—Alzheimer's disease	0.000384	0.000783	CcSEcCtD
Imiquimod—Skin disorder—Memantine—Alzheimer's disease	0.000383	0.000783	CcSEcCtD
Imiquimod—Dyspepsia—Donepezil—Alzheimer's disease	0.000383	0.000781	CcSEcCtD
Imiquimod—Hyperhidrosis—Memantine—Alzheimer's disease	0.000382	0.000779	CcSEcCtD
Imiquimod—Shock—Rivastigmine—Alzheimer's disease	0.00038	0.000776	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—Alzheimer's disease	0.000379	0.00213	CbGpPWpGaD
Imiquimod—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000379	0.000773	CcSEcCtD
Imiquimod—Decreased appetite—Donepezil—Alzheimer's disease	0.000378	0.000771	CcSEcCtD
Imiquimod—Tachycardia—Rivastigmine—Alzheimer's disease	0.000377	0.000769	CcSEcCtD
Imiquimod—TLR7—Immune System—PVRL2—Alzheimer's disease	0.000376	0.00212	CbGpPWpGaD
Imiquimod—Anorexia—Memantine—Alzheimer's disease	0.000376	0.000768	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000375	0.000766	CcSEcCtD
Imiquimod—Skin disorder—Rivastigmine—Alzheimer's disease	0.000375	0.000766	CcSEcCtD
Imiquimod—Fatigue—Donepezil—Alzheimer's disease	0.000375	0.000765	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000374	0.00211	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000373	0.000762	CcSEcCtD
Imiquimod—Pain—Donepezil—Alzheimer's disease	0.000372	0.000759	CcSEcCtD
Imiquimod—Dizziness—Galantamine—Alzheimer's disease	0.000371	0.000757	CcSEcCtD
Imiquimod—Anorexia—Rivastigmine—Alzheimer's disease	0.000368	0.000751	CcSEcCtD
Imiquimod—TLR8—Immune System—INPP5D—Alzheimer's disease	0.000368	0.00207	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—Alzheimer's disease	0.000366	0.00206	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—Alzheimer's disease	0.00036	0.00202	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00036	0.000734	CcSEcCtD
Imiquimod—Feeling abnormal—Donepezil—Alzheimer's disease	0.000358	0.000731	CcSEcCtD
Imiquimod—Insomnia—Memantine—Alzheimer's disease	0.000357	0.000729	CcSEcCtD
Imiquimod—Vomiting—Galantamine—Alzheimer's disease	0.000357	0.000728	CcSEcCtD
Imiquimod—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000356	0.000726	CcSEcCtD
Imiquimod—Paraesthesia—Memantine—Alzheimer's disease	0.000354	0.000724	CcSEcCtD
Imiquimod—TLR8—Immune System—CTSB—Alzheimer's disease	0.000354	0.00199	CbGpPWpGaD
Imiquimod—Rash—Galantamine—Alzheimer's disease	0.000354	0.000722	CcSEcCtD
Imiquimod—Dermatitis—Galantamine—Alzheimer's disease	0.000353	0.000721	CcSEcCtD
Imiquimod—TLR8—Immune System—CTSD—Alzheimer's disease	0.000352	0.00198	CbGpPWpGaD
Imiquimod—Dyspnoea—Memantine—Alzheimer's disease	0.000352	0.000718	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000352	0.00198	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000352	0.000718	CcSEcCtD
Imiquimod—Headache—Galantamine—Alzheimer's disease	0.000351	0.000717	CcSEcCtD
Imiquimod—Somnolence—Memantine—Alzheimer's disease	0.000351	0.000716	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—Alzheimer's disease	0.000349	0.00197	CbGpPWpGaD
Imiquimod—Insomnia—Rivastigmine—Alzheimer's disease	0.000349	0.000713	CcSEcCtD
Imiquimod—Dyspepsia—Memantine—Alzheimer's disease	0.000347	0.000709	CcSEcCtD
Imiquimod—TLR8—Immune System—PPP3CA—Alzheimer's disease	0.000347	0.00195	CbGpPWpGaD
Imiquimod—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000347	0.000708	CcSEcCtD
Imiquimod—Urticaria—Donepezil—Alzheimer's disease	0.000345	0.000705	CcSEcCtD
Imiquimod—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000344	0.000703	CcSEcCtD
Imiquimod—Body temperature increased—Donepezil—Alzheimer's disease	0.000344	0.000702	CcSEcCtD
Imiquimod—Abdominal pain—Donepezil—Alzheimer's disease	0.000344	0.000702	CcSEcCtD
Imiquimod—Somnolence—Rivastigmine—Alzheimer's disease	0.000343	0.000701	CcSEcCtD
Imiquimod—Decreased appetite—Memantine—Alzheimer's disease	0.000343	0.0007	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—S100B—Alzheimer's disease	0.000343	0.00193	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTK2B—Alzheimer's disease	0.000342	0.00192	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EIF2AK2—Alzheimer's disease	0.000342	0.00192	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000341	0.000696	CcSEcCtD
Imiquimod—Fatigue—Memantine—Alzheimer's disease	0.00034	0.000695	CcSEcCtD
Imiquimod—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00034	0.000694	CcSEcCtD
Imiquimod—Pain—Memantine—Alzheimer's disease	0.000338	0.000689	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CALM1—Alzheimer's disease	0.000336	0.00189	CbGpPWpGaD
Imiquimod—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000336	0.000685	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000333	0.000681	CcSEcCtD
Imiquimod—Nausea—Galantamine—Alzheimer's disease	0.000333	0.00068	CcSEcCtD
Imiquimod—Fatigue—Rivastigmine—Alzheimer's disease	0.000333	0.00068	CcSEcCtD
Imiquimod—TLR8—Immune System—GAB2—Alzheimer's disease	0.000333	0.00187	CbGpPWpGaD
Imiquimod—Pain—Rivastigmine—Alzheimer's disease	0.00033	0.000674	CcSEcCtD
Imiquimod—TLR8—Immune System—GSK3A—Alzheimer's disease	0.00033	0.00185	CbGpPWpGaD
Imiquimod—Feeling abnormal—Memantine—Alzheimer's disease	0.000325	0.000664	CcSEcCtD
Imiquimod—TLR8—Immune System—APP—Alzheimer's disease	0.000324	0.00182	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000323	0.00182	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000323	0.000659	CcSEcCtD
Imiquimod—Hypersensitivity—Donepezil—Alzheimer's disease	0.00032	0.000654	CcSEcCtD
Imiquimod—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000318	0.00065	CcSEcCtD
Imiquimod—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000316	0.000645	CcSEcCtD
Imiquimod—Urticaria—Memantine—Alzheimer's disease	0.000314	0.00064	CcSEcCtD
Imiquimod—Abdominal pain—Memantine—Alzheimer's disease	0.000312	0.000637	CcSEcCtD
Imiquimod—Body temperature increased—Memantine—Alzheimer's disease	0.000312	0.000637	CcSEcCtD
Imiquimod—Asthenia—Donepezil—Alzheimer's disease	0.000312	0.000637	CcSEcCtD
Imiquimod—Pruritus—Donepezil—Alzheimer's disease	0.000308	0.000628	CcSEcCtD
Imiquimod—Urticaria—Rivastigmine—Alzheimer's disease	0.000307	0.000626	CcSEcCtD
Imiquimod—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000305	0.000623	CcSEcCtD
Imiquimod—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000305	0.000623	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MEF2C—Alzheimer's disease	0.0003	0.00169	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000299	0.00168	CbGpPWpGaD
Imiquimod—Diarrhoea—Donepezil—Alzheimer's disease	0.000297	0.000607	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—AGER—Alzheimer's disease	0.000297	0.00167	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—Alzheimer's disease	0.000296	0.00166	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PRKCG—Alzheimer's disease	0.000294	0.00166	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—Alzheimer's disease	0.000292	0.00164	CbGpPWpGaD
Imiquimod—Hypersensitivity—Memantine—Alzheimer's disease	0.000291	0.000594	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—GSK3B—Alzheimer's disease	0.00029	0.00163	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000289	0.00162	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CREB1—Alzheimer's disease	0.000288	0.00162	CbGpPWpGaD
Imiquimod—Dizziness—Donepezil—Alzheimer's disease	0.000288	0.000587	CcSEcCtD
Imiquimod—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000285	0.000581	CcSEcCtD
Imiquimod—Asthenia—Memantine—Alzheimer's disease	0.000283	0.000578	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000281	0.00158	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.00028	0.00157	CbGpPWpGaD
Imiquimod—Pruritus—Memantine—Alzheimer's disease	0.000279	0.00057	CcSEcCtD
Imiquimod—TLR7—Immune System—INPP5D—Alzheimer's disease	0.000279	0.00157	CbGpPWpGaD
Imiquimod—Asthenia—Rivastigmine—Alzheimer's disease	0.000277	0.000566	CcSEcCtD
Imiquimod—Vomiting—Donepezil—Alzheimer's disease	0.000276	0.000564	CcSEcCtD
Imiquimod—Rash—Donepezil—Alzheimer's disease	0.000274	0.00056	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000274	0.00154	CbGpPWpGaD
Imiquimod—Dermatitis—Donepezil—Alzheimer's disease	0.000274	0.000559	CcSEcCtD
Imiquimod—Pruritus—Rivastigmine—Alzheimer's disease	0.000273	0.000558	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—Alzheimer's disease	0.000273	0.00153	CbGpPWpGaD
Imiquimod—Headache—Donepezil—Alzheimer's disease	0.000272	0.000556	CcSEcCtD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00027	0.00152	CbGpPWpGaD
Imiquimod—Diarrhoea—Memantine—Alzheimer's disease	0.00027	0.000551	CcSEcCtD
Imiquimod—TLR7—Immune System—CTSB—Alzheimer's disease	0.000268	0.00151	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTSD—Alzheimer's disease	0.000267	0.0015	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	0.000266	0.0015	CbGpPWpGaD
Imiquimod—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000264	0.000539	CcSEcCtD
Imiquimod—TLR8—Immune System—S100B—Alzheimer's disease	0.000263	0.00148	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PPP3CA—Alzheimer's disease	0.000263	0.00148	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000262	0.00148	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000261	0.00147	CbGpPWpGaD
Imiquimod—Dizziness—Memantine—Alzheimer's disease	0.000261	0.000533	CcSEcCtD
Imiquimod—TLR7—Immune System—PTK2B—Alzheimer's disease	0.000259	0.00146	CbGpPWpGaD
Imiquimod—Nausea—Donepezil—Alzheimer's disease	0.000258	0.000527	CcSEcCtD
Imiquimod—Dizziness—Rivastigmine—Alzheimer's disease	0.000255	0.000521	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CALM1—Alzheimer's disease	0.000255	0.00143	CbGpPWpGaD
Imiquimod—TLR7—Immune System—GAB2—Alzheimer's disease	0.000252	0.00142	CbGpPWpGaD
Imiquimod—Vomiting—Memantine—Alzheimer's disease	0.000251	0.000512	CcSEcCtD
Imiquimod—TLR7—Immune System—GSK3A—Alzheimer's disease	0.00025	0.00141	CbGpPWpGaD
Imiquimod—Rash—Memantine—Alzheimer's disease	0.000249	0.000508	CcSEcCtD
Imiquimod—Dermatitis—Memantine—Alzheimer's disease	0.000249	0.000508	CcSEcCtD
Imiquimod—Headache—Memantine—Alzheimer's disease	0.000247	0.000505	CcSEcCtD
Imiquimod—TLR7—Immune System—APP—Alzheimer's disease	0.000246	0.00138	CbGpPWpGaD
Imiquimod—Vomiting—Rivastigmine—Alzheimer's disease	0.000246	0.000501	CcSEcCtD
Imiquimod—Rash—Rivastigmine—Alzheimer's disease	0.000244	0.000497	CcSEcCtD
Imiquimod—Dermatitis—Rivastigmine—Alzheimer's disease	0.000243	0.000497	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000242	0.00136	CbGpPWpGaD
Imiquimod—Headache—Rivastigmine—Alzheimer's disease	0.000242	0.000494	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—BCL2—Alzheimer's disease	0.000241	0.00136	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1A—Alzheimer's disease	0.000238	0.00134	CbGpPWpGaD
Imiquimod—Nausea—Memantine—Alzheimer's disease	0.000234	0.000479	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000231	0.0013	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000231	0.0013	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MEF2C—Alzheimer's disease	0.00023	0.0013	CbGpPWpGaD
Imiquimod—Nausea—Rivastigmine—Alzheimer's disease	0.000229	0.000468	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.000229	0.00129	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AGER—Alzheimer's disease	0.000228	0.00129	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000226	0.00127	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRKCG—Alzheimer's disease	0.000226	0.00127	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000222	0.00125	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—GSK3B—Alzheimer's disease	0.00022	0.00124	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CREB1—Alzheimer's disease	0.000218	0.00123	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000214	0.00121	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000211	0.00119	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000209	0.00117	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000205	0.00116	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000203	0.00114	CbGpPWpGaD
Imiquimod—TLR7—Immune System—S100B—Alzheimer's disease	0.0002	0.00112	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK8—Alzheimer's disease	0.000196	0.0011	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CALM1—Alzheimer's disease	0.000196	0.0011	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.000185	0.00104	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—BCL2—Alzheimer's disease	0.000183	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1A—Alzheimer's disease	0.000181	0.00102	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000175	0.000983	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MEF2C—Alzheimer's disease	0.000175	0.000983	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AGER—Alzheimer's disease	0.000173	0.000974	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000171	0.000964	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PRKCG—Alzheimer's disease	0.000171	0.000964	CbGpPWpGaD
Imiquimod—TLR8—Immune System—GSK3B—Alzheimer's disease	0.000169	0.00095	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CREB1—Alzheimer's disease	0.000167	0.000942	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000165	0.000931	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	0.000159	0.000893	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000153	0.000861	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK8—Alzheimer's disease	0.000148	0.000834	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CALM1—Alzheimer's disease	0.000148	0.000834	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BCL2—Alzheimer's disease	0.000141	0.000791	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	0.000132	0.000745	CbGpPWpGaD
Imiquimod—TLR7—Immune System—GSK3B—Alzheimer's disease	0.000128	0.00072	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CREB1—Alzheimer's disease	0.000127	0.000714	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—Alzheimer's disease	0.000125	0.000703	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—Alzheimer's disease	0.000124	0.000699	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000124	0.000697	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	0.000123	0.000693	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000123	0.000689	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	0.00012	0.000677	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	0.000118	0.000664	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000116	0.000655	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—Alzheimer's disease	0.000115	0.000648	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK8—Alzheimer's disease	0.000114	0.000641	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000111	0.000623	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—Alzheimer's disease	0.000107	0.000599	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000104	0.000587	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000102	0.000575	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	9.57e-05	0.000539	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—Alzheimer's disease	9.47e-05	0.000533	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—Alzheimer's disease	9.42e-05	0.00053	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	9.29e-05	0.000522	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	9.11e-05	0.000512	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.98e-05	0.000505	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	8.94e-05	0.000503	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	8.94e-05	0.000503	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—Alzheimer's disease	8.74e-05	0.000491	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK8—Alzheimer's disease	8.64e-05	0.000486	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—Alzheimer's disease	7.28e-05	0.000409	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	6.82e-05	0.000384	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—Alzheimer's disease	6.71e-05	0.000378	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.36e-05	0.000358	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA4—Alzheimer's disease	5.8e-05	0.000326	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.67e-05	0.000319	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—Alzheimer's disease	5.51e-05	0.00031	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	5.45e-05	0.000307	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.26e-05	0.000296	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	5.17e-05	0.000291	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—Alzheimer's disease	5.09e-05	0.000286	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLD3—Alzheimer's disease	4.93e-05	0.000277	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.93e-05	0.000277	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.87e-05	0.000274	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	4.73e-05	0.000266	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.62e-05	0.00026	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	4.55e-05	0.000256	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.47e-05	0.000252	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ND1—Alzheimer's disease	4.39e-05	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.29e-05	0.000242	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.21e-05	0.000237	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.99e-05	0.000224	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.93e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.81e-05	0.000214	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.65e-05	0.000205	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.51e-05	0.000198	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.39e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.39e-05	0.00019	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.08e-05	0.000173	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TPI1—Alzheimer's disease	2.83e-05	0.000159	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CHAT—Alzheimer's disease	2.83e-05	0.000159	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAOB—Alzheimer's disease	2.71e-05	0.000153	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	2.61e-05	0.000147	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.58e-05	0.000145	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.56e-05	0.000144	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—A2M—Alzheimer's disease	2.52e-05	0.000142	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.25e-05	0.000127	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.2e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.19e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.19e-05	0.000123	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.17e-05	0.000122	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.1e-05	0.000118	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.06e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.06e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.02e-05	0.000114	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.02e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.95e-05	0.00011	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.91e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.8e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.77e-05	9.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.75e-05	9.84e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.69e-05	9.53e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.67e-05	9.42e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.59e-05	8.93e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.59e-05	8.93e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.56e-05	8.76e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.51e-05	8.48e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.5e-05	8.44e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.48e-05	8.3e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.39e-05	7.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.37e-05	7.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.35e-05	7.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.24e-05	6.95e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.16e-05	6.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.16e-05	6.52e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.15e-05	6.5e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.15e-05	6.47e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.14e-05	6.41e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.06e-05	5.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1e-05	5.64e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—Alzheimer's disease	9.83e-06	5.53e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.54e-06	5.37e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.91e-06	5.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.88e-06	5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.8e-06	4.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—Alzheimer's disease	8.62e-06	4.85e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	7.88e-06	4.44e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.74e-06	4.35e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—Alzheimer's disease	7.59e-06	4.27e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.65e-06	3.74e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.08e-06	3.42e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—Alzheimer's disease	3.96e-06	2.23e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.06e-06	1.72e-05	CbGpPWpGaD
